Day: December 15, 2021

Imaged on PhenoCycler-Fusion Zoom InA zoomed in section shows germinal centers with a concentration of B cells (in cyan) where typically antibody-secreting plasma-cells and memory B-cells are formed, to protect against invading pathogens.Imaged on PhenoCycler-FusionA whole slide human FFPE sample with more than 3 million cells, imaged on the PhenoCycler-Fusion.-Company previews an integrated suite of solutions, including the new PhenoCycler™-Fusion System for unbiased spatial discovery, at unprecedented speeds -Innovations include a novel spatial transcriptomics chemistry and universal protein chemistry for accelerated biomarker discovery and validation MARLBOROUGH, Mass., Dec. 15, 2021 (GLOBE NEWSWIRE) — Akoya Biosciences, Inc., (Nasdaq: AKYA), The Spatial Biology Company®, today unveiled its...

Issuance of 2nd tranche of €500,000 of notes convertibles into new shares DEINOVE strengthens its cash position to finance its working capital needs and the pursuance of the Phase II clinical trial evaluating DNV3837 in patients with severe Clostridioides difficile infection DEINOVE (Euronext Growth Paris: ALDEI), a French biotech company, pioneer in the exploration and exploitation of bacterial biodiversity to address the urgent, global challenge of antibiotic resistance, announces today the issuance of a 2nd tranche of notes convertible into new shares (the “OC“) as part of the agreement entered into in September 20211 with the European Select Growth Opportunities Fund (the “Investor“) relating to a financing through the issuance of OC for a maximum nominal amount of €10 million, with a 5% face discount upon conversion...

Financial press release Vranken-Pommery Monopole Group sets up a €60 million USPP Reims, December 15, 2021 The Group, through its subsidiary Vranken-Pommery Production, has finalized a €60 million bond issue in the form of a private placement with Barings. As part of its debt reduction plan and in a context of strong business recovery, Vranken-Pommery Monopole is securing a significant part of its debt with a €60 million ten-year bond at 2.67%. By diversifying its sources of financing, Vranken-Pommery Monopole Group demonstrates its long-term attractiveness to leading international investors interested in its commitment to sustainable development. The vineyards of Provence and Camargue are classified as “Organic”, and the vineyards of Champagne as “VDC”. This document does not constitute an offer of securities...

Nanterre, 15 December 2021 VINCI Autoroutes and VINCI Airports traffic in November 2021 I-      Change in VINCI Autoroutes’ intercity networks traffic  November YTD at the end of November(11 months)  % change 2021/2020 % change 2021/2019 % change 2021/2020 % change 2021/2019VINCI Autoroutes +85.3% +6.7% +21.9% −4.4%Light vehicles +116.4%1 +6.7% +24.1% −5.5%Heavy vehicles +6.8% +6.7% +10.6% +2.4%1 Light-vehicle traffic contracted in November 2020, reflecting the effect of the restrictions applied in France – notably the lockdown imposed from 30 October to 15 December 2020 – and in Europe. Good traffic trends for VINCI Autoroutes continued. In November 2021, all vehicle categories combined, traffic was up 6.7% compared to November 2019. II-      Change in VINCI Airport passenger traffic2  November YTD at the end...

Suominen Corporation ANNOUNCEMENT 15.12.2021          Suominen Corporation: SHARE REPURCHASE 15.12.2021     In the Helsinki Stock Exchange         Trade date 15.12.2021  Bourse trade Buy  Share SUY1V  Amount 1,833 SharesAverage price/ share 4.9087 EURTotal cost 8,997.65 EUR          Suominen Corporation now holds a total of 887 259 sharesincluding the shares repurchased on 15.12.2021          On behalf of Suominen Corporation       Nordea Bank Oyj         Janne Sarvikivi Sami Huttunen       For additional information, please contact:  Toni Tamminen, CFO, Suominen Corporation  tel. +358 (0)10 214 3051         www.suominen.fi    AttachmentSuominen 15.12 trades

Apex National Cloud & Cloud Security Transformation Virtual SummitRackspace Technology Chief Product Officer, Josh Prewitt, will conduct a fireside chat with McGraw Hill Education CTO Andrew Lippert on “Expanding Educational Horizons in the Cloud” at the Apex National Cloud & Cloud Security Transformation Virtual SummitSAN ANTONIO, Dec. 15, 2021 (GLOBE NEWSWIRE) — Rackspace Technology® (NASDAQ: RXT), a leading end-to-end, multicloud technology solutions company, today announced Rackspace Technology Chief Product Officer, Josh Prewitt, will conduct a fireside chat with McGraw Hill Education CTO Andrew Lippert on “Expanding Educational Horizons in the Cloud” at the Apex National Cloud & Cloud Security Transformation Virtual Summit. The Apex Assembly will be bringing together 60+ CIOs and other Divisional...

Innofactor Plc ANNOUNCEMENT 15.12.2021          INNOFACTOR PLC: SHARE REPURCHASE 15.12.2021       In the Helsinki Stock Exchange         Trade date 15.12.2021  Bourse trade Buy  Share IFA1V  Amount 18,000 SharesAverage price/ share 1.4000 EURTotal cost 25,200.00 EUR          Innofactor Plc now holds a total of 602 000 sharesincluding the shares repurchased on 15.12.2021          On behalf of Innofactor Plc         Nordea Bank Oyj         Janne Sarvikivi Sami Huttunen       Additional information:    Sami Ensio, CEO    Innofactor Plc    Tel. +358 50 584 2029    sami.ensio@innofactor.com         www.innofactor.com       AttachmentInnofactor_15.12_trades

Sandusky, OH, Dec. 15, 2021 (GLOBE NEWSWIRE) — PAO Group, Inc. (OTC Pink: PAOG) today announced the company’s line of “RX” branded full spectrum CBD products are now available for sale at www.usmj.com. PAOG is developing both pharmaceutical and nutraceutical treatments based on its own proprietary extraction technology. The RX branded products are PAOG’s first nutraceutical products. The RX branded products have been well received and are now available for sale direct to consumers at www.usmj.com. PAOG management today introduced the direct to consumer sales through www.usmj.com with a tongue-in-cheek reference to the impending monetary policy update from the Federal Reserve. The RX products available now at www.usmj.com include: Relax RX Full spectrum CBD Soft gels 900mg Remain Calm and Cool… Oral cannabidiol (CBD), the...

Announcement no. 57/2021 Financial Calendar The following dates for announcement of financial reporting and holding of general meeting have been set: 10 February 2022        Preliminary statement of financial results 2021 3 March 2022                Annual report 2021 27 April 2022                Annual General Meeting 12 May 2022                Interim Report Q1 2022 18 August 2022                Interim Report Q2 2022 10 November 2022        Interim Report Q3 2022 Contact Please direct any questions regarding this announcement to: Senior Investor Relations OfficerMikael Bo LarsenMobile no. +45 5143 8002AttachmentAS 57 2021 – Financial Calendar